Investigation of the antioxidant effects of Trolox on HT-29 colon cancer cells
Experimental Biomedical Research · 20.03.2026
DOI: 10.30714/j-ebr.2026.274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Biomedical Research, online erschienen am 20.03.2026. Verfasst von Fatma Yesilyurt und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
To elucidate the effect of Trolox on HT-29 colon cancer cells and shed light on its therapeutic potential in the treatment of colorectal cancer.
Methods
HT-29 cells were obtained from Atatürk University, Department of Medical Pharmacology (Erzurum, Turkey). Trolox doses (0.1, 1, 10, 100, and 1000 μM) were added to HT-29 cells under cell culture conditions. After 24 hours, cell viability was determined by 3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazoliumbromide (MTT). Total antioxidant capacity (TAC), total oxidant status (TOS), superoxide dismutase (SOD), and lactate dehydrogenase (LDH) were analyzed. MTT and ELISA data were evaluated using the One-Way Analysis of Variance (One-Way ANOVA) technique with GraphPad 9.5 software.
Results
While the viability of the control group was 100%, the viability of the other groups was proportional. Viability decreased at different Trolox dosages. Viability rates were lowest at 100 µM and 1000 µM concentrations. The IC50 value of Trolox in HT-29 cells was calculated as 866.26 µM. Statistical analysis showed significant findings. MTT results were consistent with our TAC, TOS, SOD and LDH analyses.
Conclusion
Our study demonstrates that high concentrations of Trolox exert a cytotoxic effect on HT-29 cells by depleting antioxidant defenses and inducing oxidative stress, acting as a pro-oxidant.
Zitieren
APA
Yesilyurt, F., Akcay, G., Ates, D., Karakoc, E., & Yaman, S. (2026). Investigation of the antioxidant effects of Trolox on HT-29 colon cancer cells. Experimental Biomedical Research. https://doi.org/10.30714/j-ebr.2026.274
Vancouver
Yesilyurt F, Akcay G, Ates D, Karakoc E, Yaman S. Investigation of the antioxidant effects of Trolox on HT-29 colon cancer cells. Experimental Biomedical Research. 2026. doi:10.30714/j-ebr.2026.274
BibTeX
@article{Yesilyurt2026,
author = {Yesilyurt, Fatma and Akcay, Güven and Ates, Dilanur and Karakoc, Esra and Yaman, Selma},
title = {Investigation of the antioxidant effects of Trolox on HT-29 colon cancer cells},
journal = {Experimental Biomedical Research},
year = {2026},
doi = {10.30714/j-ebr.2026.274}
}
EUVIMED